Wayland Group Corp Stock Fundamentals

MRRCF Stock  USD 0.0001  0.00  0.00%   
Wayland Group Corp fundamentals help investors to digest information that contributes to Wayland Group's financial success or failures. It also enables traders to predict the movement of Wayland Pink Sheet. The fundamental analysis module provides a way to measure Wayland Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wayland Group pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Wayland Group Corp Company Return On Asset Analysis

Wayland Group's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Wayland Group Return On Asset

    
  -0.3  
Most of Wayland Group's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wayland Group Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Wayland Group Corp has a Return On Asset of -0.2952. This is 96.63% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 110.86% higher than that of the company.

Wayland Group Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Wayland Group's current stock value. Our valuation model uses many indicators to compare Wayland Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wayland Group competition to find correlations between indicators driving Wayland Group's intrinsic value. More Info.
Wayland Group Corp is regarded third in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Wayland Group's earnings, one of the primary drivers of an investment's value.

Wayland Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wayland Group's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Wayland Group could also be used in its relative valuation, which is a method of valuing Wayland Group by comparing valuation metrics of similar companies.
Wayland Group is currently under evaluation in return on asset category among its peers.

Wayland Fundamentals

About Wayland Group Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Wayland Group Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wayland Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wayland Group Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. The company was founded in 2013 and is headquartered in Oakville, Canada. WAYLAND GROUP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 68 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Wayland Pink Sheet

Wayland Group financial ratios help investors to determine whether Wayland Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wayland with respect to the benefits of owning Wayland Group security.